-+ 0.00%
-+ 0.00%
-+ 0.00%

Australian AI Stocks With Recurring Revenue and Enterprise Demand

Simply Wall St·08/10/2026 00:27:01
语音播报

Global inflation expectations are easing and AI hardware demand in Asia is still firm. That mix keeps growth stories in focus, while long term interest rate pressure looks less intense than a year ago. Smaller AI focused companies can often move faster than giants, and the AI Small Caps screener is built to surface them. This article highlights three AI small cap stocks worth a closer look.

The three stocks in this article are just a starting sample, and the full screen surfaced 3 more AI focused small caps with equally compelling narratives that are not covered below. To identify and analyze those additional opportunities alongside the stocks featured here, head straight into the AI Small Caps screener.

ImExHS (ASX:IME)

Overview: ImExHS is a Sydney based health tech company that provides cloud based medical imaging software and outsourced radiology services, helping hospitals and clinics manage radiology, cardiology and pathology workflows through its AQUILA, ALULA and ANTEROS platforms. It also supplies teleradiology and diagnostic reporting services, which link directly into its software and support the development of AI tools for image interpretation.

Operations: ImExHS generates about A$10 million from Software and A$19 million from Radiology services, with revenue of roughly A$29 million largely earned in Latin America.

Market Cap: A$17 million

ImExHS sits at the intersection of cloud software, AI and healthcare delivery. This combination is a common focus for many investors interested in smaller AI focused companies. Its Aquila+ platform and outsourced radiology arm work together, so every new deployment or contract can feed more data into AI tools that aim to cut costs and speed up reporting. Analysts expect earnings to improve from a current loss to A$5.2 million by 2029, although that outcome depends on hospitals accepting higher contract values and on timely payments from Latin American health systems. Together with questions about board refresh and a heavy reliance on external funding, this creates a higher risk profile that may warrant a closer look for investors who are comfortable with early stage turnarounds.

ImExHS sits on a growing pool of imaging data that could matter far more than its A$17 million market cap suggests. Get the full story through the analysis report for ImExHS and why that dataset might be the real swing factor.

ASX:IME Earnings & Revenue Growth as at Aug 2026
ASX:IME Earnings & Revenue Growth as at Aug 2026

Build your own healthcare AI shortlist

ImExHS and the two other AI stocks in this article all came out of the same screener, but the real edge is in tailoring the filters to what matters most to you. Use our flexible Screener to combine valuation, growth, quality and risk checks into your own watchlist, or jump straight into our curated Investing Ideas for ready made starting points.

Dicker Data (ASX:DDR)

Overview: Dicker Data is an Australian based wholesale distributor that supplies IT hardware, software, cloud and IoT solutions to corporate and commercial customers, helping vendors reach resellers and end users with everything from AI ready data center equipment and cybersecurity tools to PCs, printers and networking gear across Australia and New Zealand.

Operations: Dicker Data generates around A$2.6b in revenue from wholesale distribution of computer peripherals, with most sales in Australia and a smaller contribution from New Zealand.

Market Cap: A$2.4b

Dicker Data gives you exposure to enterprise AI, cybersecurity and data center spending through a company that already has scale, long standing vendor ties and a broad reseller network. Growth in higher margin software and security revenue, supported by partnerships such as CrowdStrike and AI infrastructure projects, sits alongside steady PC and device demand and a regular dividend. At the same time, heavy reliance on debt, pressure on gross margins from large low margin deals and reliance on Australia and New Zealand keep risk firmly on the table. The key consideration is whether the AI and software mix shift can offset those pressures over the next few years.

Dicker Data sits where AI hardware, security and cloud spending meet. Yet the real story may be how its mix of software, margin pressure and debt stack up in the analysis report for Dicker Data

ASX:DDR Revenue & Expenses Breakdown as at Aug 2026
ASX:DDR Revenue & Expenses Breakdown as at Aug 2026

Data#3 (ASX:DTL)

Overview: Data#3 is a Brisbane based IT solutions provider that helps businesses, government and education customers manage cloud, security, data and AI, collaboration tools and devices, backed by consulting, managed services and software licensing support.

Operations: Data#3 generates most of its revenue from Infrastructure Solutions at about A$551 million, with Services contributing around A$262 million and Software Solutions about A$71 million, plus a small amount from other activities.

Market Cap: A$1.5 billion

Data#3 catches attention because it couples high quality fundamentals with clear exposure to cloud, security and AI spending. Recurring subscription and Device as a Service contracts now make up a large share of sales, helping support more predictable revenue, while a 58.1% ROE and earnings growth of around 10% per year over both one and five years point to an efficient business model. At the same time, the stock already trades on a premium P/E and analysts see earnings growth that is solid rather than explosive, so expectations are not low. Dependence on major partners like Microsoft, pressure on dividends that are not fully covered, and a funding base of external borrowings mean the full picture on risk and reward deserves careful attention before making any decision.

Data#3 combines high quality fundamentals, a 58.1% ROE and subscription style revenue that many investors follow. Yet the real question is how that premium P/E holds up in the analyst forecasts for Data#3 that could shift the whole story.

ASX:DTL P/E Ratio as at Aug 2026
ASX:DTL P/E Ratio as at Aug 2026

Seeking Fresh Alternatives Beyond These AI Stocks

Fresh opportunities can move from quiet to breakout before most investors even notice. Use these curated lists while they are still under the radar for now and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.